Results from first phase II trial of orally active PAF inhibitor in multiple sclerosis discouraging June 22, 1999
Higher doses of levetiracetam evaluated for efficacy and, particularly, tolerability in epileptics June 21, 1999
New class of tachykinin antagonists synthesized at MS&D, particularly useful for emesis June 18, 1999
RSS